Form 4 for INCY Incyte
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001209191-23-011110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | INCY | Dhanak Dashyant | EVP, CSO | M - OptEx | $65.42 | +3,693 | 57.0K | +7% | +$241.6K |
| D | 2023-02-21 | 2023-02-16 | INCY | Dhanak Dashyant | EVP, CSO | M - OptEx | $0.00 | -3,693 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | M | A | 3,693 | $65.42 | 56,956 | D | — | — | (F1) This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. |
| 2 | Derivative | Incentive Stock Option (right to buy) | 2023-02-16 | M | D | 3,693 | $0.00 | 0 | D | $65.42 · — to 2028-12-10 | 3,693 Common Stock | (F2) Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |